BioNTech/Pfizer coronavirus vaccine 100 percent effective in teens at 4 months

No serious safety concerns were observed in those with at least six months of safety follow-up data, companies say.

Related Keywords

,Drug Administration ,European Medicines Agency On ,Pfizer Monday ,European Medicines Agency ,Clinical Trials ,Coronavirus ,Drug And Device Safety ,Hospitals ,Infectious Diseases ,Patients ,Pharma ,Regulation ,Research ,Vaccines ,